The Effect of Phloroglucinol in Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled Trial
2020
Background/Aims
We aim to evaluate the efficacy and safety of phloroglucinol in patients with diarrhea-predominant irritable bowel syndrome (IBS-D).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
46
References
7
Citations
NaN
KQI